- Home
- CRVL vs ELAN Comparison
CRVL vs ELAN Comparison
Compare CRVL & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVL
- ELAN
- Stock Information
- Founded
- CRVL 1987
- ELAN 1954
- Country
- CRVL United States
- ELAN United States
- Employees
- CRVL N/A
- ELAN N/A
- Industry
- CRVL Specialty Insurers
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- CRVL Finance
- ELAN Health Care
- Exchange
- CRVL Nasdaq
- ELAN Nasdaq
- Market Cap
- CRVL 5.9B
- ELAN 6.0B
- IPO Year
- CRVL 1991
- ELAN 2018
- Fundamental
- Price
- CRVL $109.56
- ELAN $13.42
- Analyst Decision
- CRVL
- ELAN Buy
- Analyst Count
- CRVL 0
- ELAN 6
- Target Price
- CRVL N/A
- ELAN $15.17
- AVG Volume (30 Days)
- CRVL 129.1K
- ELAN 6.4M
- Earning Date
- CRVL 07-29-2025
- ELAN 05-07-2025
- Dividend Yield
- CRVL N/A
- ELAN N/A
- EPS Growth
- CRVL 24.49
- ELAN N/A
- EPS
- CRVL 1.83
- ELAN 0.75
- Revenue
- CRVL $895,589,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- CRVL N/A
- ELAN $3.85
- Revenue Next Year
- CRVL N/A
- ELAN $4.88
- P/E Ratio
- CRVL $60.85
- ELAN $17.90
- Revenue Growth
- CRVL 12.61
- ELAN 1.42
- 52 Week Low
- CRVL $76.53
- ELAN $8.02
- 52 Week High
- CRVL $128.61
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- CRVL 44.14
- ELAN 69.54
- Support Level
- CRVL $109.12
- ELAN $13.09
- Resistance Level
- CRVL $112.60
- ELAN $13.69
- Average True Range (ATR)
- CRVL 2.77
- ELAN 0.41
- MACD
- CRVL -0.24
- ELAN -0.05
- Stochastic Oscillator
- CRVL 6.13
- ELAN 56.67
About CRVL CorVel Corp.
CorVel Corp applies technology including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies, and government agencies in managing worker's compensation and health, auto, and liability services. The company's solutions combine integrated technologies with a human touch providing services that include claims management, bill review, preferred provider networks, utilization management, case management, pharmacy services, directed care, and medicare services.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.